GIST

Activity of dasatinib, a dual SRC/ABL kinase inhibitor, and IPI-504, a heat shock protein 90 inhibitor, against gastrointestinal stromal tumor-associated PDGFRAD842V mutation.

Dewaele B, Wasag B, Cools J, Sciot R, Prenen H, Vandenberghe P, Wozniak A, Schoffski P, Marynen P, Debiec-Rychter M.

Clin Cancer Res. 2008 Sep 15;14(18):5749-58.

PMID 18794084

WordNet

the 9th letter of the Roman alphabet (同)i

PrepTutorEJDIC

『私は』私が
iodineの化学記号
(野球で)innings pitched

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. びまん性大細胞型B細胞性リンパ腫の予後 prognosis of diffuse large b cell lymphoma
2. マントル細胞リンパ腫の臨床症状、病理学的特徴、および診断 clinical manifestations pathologic features and diagnosis of mantle cell lymphoma
3. Clinical manifestations, pathologic features, and diagnosis of systemic anaplastic large cell lymphoma
4. 濾胞性リンパ腫の臨床症状、病理学的特徴、診断、および予後 clinical manifestations pathologic features diagnosis and prognosis of follicular lymphoma
5. びまん性大細胞型B細胞性リンパ腫の疫学、臨床症状、病理学的特徴、および診断 epidemiology clinical manifestations pathologic features and diagnosis of diffuse large b cell lymphoma

English Journal

Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression.

Sánchez-Martín D1, Otsuka A1, Kabashima K1, Ha T1, Wang D1, Qian X1, Lowy DR1, Tosato G1.
Journal of the National Cancer Institute.J Natl Cancer Inst.2017 Nov 30. doi: 10.1093/jnci/djx219. [Epub ahead of print]
PMID 29202196

Tumor Suppression Efficacy of Heat Shock Protein 90 Inhibitor 17AAG in a Liposarcoma Mouse Model.

Nam S1,2, Kim H2, Hong D2, Park JB1,2,3, Kim SJ4,2,3.
Anticancer research.Anticancer Res.2017 Nov;37(11):6291-6302.
PMID 29061812

Synergistic anti-tumor effect of 17AAG with the PI3K/mTOR inhibitor NVP-BEZ235 on human melanoma.

Calero R1, Morchon E2, Martinez-Argudo I3, Serrano R4.
Cancer letters.Cancer Lett.2017 Oct 10;406:1-11. doi: 10.1016/j.canlet.2017.07.021. Epub 2017 Aug 1.
PMID 28774796

In vitro investigation of the effect of matrix molecules on the behavior of colon cancer cells under the effect of geldanamycin derivative.

Vural K1, Kosova F2, Kurt FÖ3, Tuğlu İ4.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.Tumour Biol.2017 Oct;39(10):1010428317720569. doi: 10.1177/1010428317720569.
PMID 29034805

Japanese Journal

HSP90阻害薬の幕開け : 非小細胞肺がんを中心に (抗がん剤治療の最前線 : 分子標的薬剤の使用による進歩(前篇)) -- (新たな標的となる遺伝子とその変異,新薬)

最新医学 67(-), 1534-1542, 2012-06
NAID 40019368001

Related Pictures

IPI 504, Retaspamycin, Retaspimycin « New IPI-504 retaspimycin HSP90 inhibitor IPI Combination of IPI-504 and docetaxel (DTX >> IPI-504 (Retaspimycin hydrochloride IPI-504 (Retaspimycin HCl) | Hsp90